Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New French call for type 2 diabetes testing:

This article was originally published in Clinica

Executive Summary

There is a renewed drive in France for screening for type 2 diabetes which, if caught early can prevent the onset of medical complications. It is estimated that of the 3 million diabetics in France, some 800,000 are unaware of their condition because of the lack of screening. Professor Philippe Passa of the Saint-Louis Hospital in Paris is calling for all patients presenting with repeated infections to have a glycaemia test, and for all those over 40 with a family history of type 2 diabetes to be screened every other year, even though they have no symptoms. Capillary glycaemia testing should also be routine in workplace medicine, and followed up with a laboratory test where positive, Professor Passa recommends.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT064843

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel